Octave
About Octave
Octave’s Precision Care Solution is the first-of-its-kind that accurately and objectively measures, and helps manage, complex and high-cost neurodegenerative diseases, starting with multiple sclerosis. Octave developed the first and only multivariate blood test to measure MS disease activity, enhanced MRI analytics and protocols, and a digital clinical program with Octave MS care partners to provide continuity of care. Provider: The solution provides neurologists with a longitudinal and holistic perspective of the patient along with comprehensive and actionable insights, enabling more confident and informed care decisions. Payer: The integrated and multi-dimensional approach allows payers to reduce total cost of care by optimizing healthcare medications and utilization (hospitalizations, ER visits, MRIs, labs). Pharma: Octave enables pharma to optimize the entire lifecycle of drug discovery & development as well as clinical trials and post marketing with real world evidence. Through purposeful problem solving and innovative technologies, Octave’s platform generates, analyzes and combines data to create a new paradigm of MS care, leading to improved patient outcomes.
Company Metrics
- Employees: 51-100
- Monthly Visits: None
- Tech Stack: None active products
Financial Information
- Estimated Revenue: Less than $1M
- Total Funding: 48500000 USD
- Last Funding: None (Venture - Series Unknown)
- Funding Status:
Technology Stack
Octave actively uses None products in their tech stack.
Market Presence
Industries: Biotechnology, Clinical Trials, Health Care, Health Diagnostics, Medical
Headquarters: Menlo Park, California, United States
Leadership
- Suhas Mhaskar - Executive Director & CIO LinkedIn
Employees
- Jennifer Ryan - Manager of Partner Success (LinkedIn)
- Curtis Koyama - Senior Lead, Partner Success (LinkedIn)
- Erwan Rivet - Chief Technology Officer (LinkedIn)
- Maital Rasmussen - Chief Commercial Officer (LinkedIn)
- Mike Edgeworth - Chief Population Health Officer (LinkedIn)